ArriVent BioPharma stockAVBP
ArriVent BioPharma trades at $12.23, 65.9% below its 52-week high (Jun 26, 2026). The price is below its 50- and 200-day averages, a downtrend. −39.2% year to date, −33.3% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 18, 2026.
Ratings, candles, signals and the screener for AVBP — after you log in
Open the terminalFrequently asked questions about ArriVent BioPharma
What is the ArriVent BioPharma stock price?
At the close on Nov 5, 2026: $12.23 (−9.34% on the day). 52-week high: $35.83 on Jun 26, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does ArriVent BioPharma report earnings?
The next quarterly report is on Nov 18, 2026. Last quarter, earnings per share changed −17% year over year, revenue 0%.
Does ArriVent BioPharma pay dividends?
No, ArriVent BioPharma does not pay dividends.
Where does ArriVent BioPharma trade and how to buy it?
Ticker AVBP, exchange Nasdaq, listed since 2024. You can buy it through a broker with access to US exchanges.
Should I buy ArriVent BioPharma now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for AVBP are in the terminal after you log in.